|
1
|
Wang J and Yue X: Role and importance of
the expression of transcription factor FOXC2 in cervical cancer.
Oncol Lett. 14:6627–6631. 2017.PubMed/NCBI
|
|
2
|
Tsakogiannis D, Moschonas GD, Bella E,
Kyriakopoulou Z, Amoutzias GD, Dimitriou TG, Kottaridi C and
Markoulatos P: Association of p16 (CDKN2A) polymorphisms with the
development of HPV16-related precancerous lesions and cervical
cancer in the Greek population. J Med Virol. 90:965–971. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Senapati R, Nayak B, Kar SK and Dwibedi B:
HPV genotypes co-infections associated with cervical carcinoma:
Special focus on phylogenetically related and non-vaccine targeted
genotypes. PLoS One. 12:e01878442017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gilmore TD: Introduction to NF-kappaB:
players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Epinat JC and Gilmore TD: Diverse agents
act at multiple levels to inhibit the Rel/NF-kappaB signal
transduction pathway. Oncogene. 18:6896–6909. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilmore TD: The Rel/NF-kappaB signal
transduction pathway: Introduction. Oncogene. 18:6842–6844. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: An actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takahashi K and Nadal-Ginard B: Molecular
cloning and sequence analysis of smooth muscle calponin. J Biol
Chem. 266:13284–13288. 1991.PubMed/NCBI
|
|
10
|
Prasad PD, Stanton JA and Assinder SJ:
Expression of the actin-associated protein transgelin (SM22) is
decreased in prostate cancer. Cell Tissue Res. 339:337–347. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leung WK, Ching AK, Chan AW, Poon TC, Mian
H, Wong AS, To KF and Wong N: A novel interplay between oncogenic
PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of
liver cancer cell motility. Oncogene. 30:4464–4475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leinweber BD, Leavis PC, Grabarek Z, Wang
CL and Morgan KG: Extracellular regulated kinase (ERK) interaction
with actin and the calponin homology (CH) domain of actin-binding
proteins. Biochem J. 344:117–123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nair RR, Solway J and Boyd DD: Expression
cloning identifies transgelin (SM22) as a novel repressor of 92-kDa
type IV collagenase (MMP-9) expression. J Biol Chem.
281:26424–26436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nohata N, Sone Y, Hanazawa T, Fuse M,
Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa
M, et al: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in
head and neck squamous cell carcinoma. Oncotarget. 2:29–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawakami K, Enokida H, Chiyomaru T,
Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama
K, Nohata N, et al: The functional significance of miR-1 and
miR-133a in renal cell carcinoma. Eur J Cancer. 48:827–836. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodes LV, Nitschke AM, Segar HC, Martin
EC, Driver JL, Elliott S, Nam SY, Li M, Nephew KP, Burow ME and
Collins-Burow BM: The histone deacetylase inhibitor trichostatin A
alters microRNA expression profiles in apoptosis-resistant breast
cancer cells. Oncol Rep. 27:10–16. 2012.PubMed/NCBI
|
|
17
|
American College of Obstetricians and
Gynecologists, . ACOG practice bulletin. Diagnosis and treatment of
cervical carcinomas. Number 35, May 2002. American College of
Obstetricians and Gynecologists. Int J Gynecol Obstet. 78:79–91.
2002.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stehman FB, Rose PG, Greer BE, Roy M,
Plante M, Penalver M, Jhingran A, Eifel P, Montz F and Wharton JT:
Innovations in the treatment of invasive cervical cancer. Cancer.
98:2052–2063. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Munagala R, Donà MG, Rai SN, Jenson AB,
Bala N, Ghim SJ and Gupta RC: Significance of multiple HPV
infection in cervical cancer patients and its impact on treatment
response. Int J Oncol. 34:263–271. 2009.PubMed/NCBI
|
|
22
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Radisky DC: Epithelial-mesenchymal
transition. Cancer Res. 118:4325–4326. 2005.
|
|
24
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang TL, Lee LY, Wang CC, Liang Y, Huang
SF and Wu CM: Claudin-4 expression is associated with tumor
invasion, MMP-2 and MMP-9 expression in gastric cancer. Exp Ther
Med. 1:789–797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith MC, Luker KE, Garbow JR, Prior JL,
Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of
both primary and metastatic breast cancer. Cancer Res.
64:8604–8612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tachibana K, Hirota S, Iizasa H, Yoshida
H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N,
Nishikawa S, et al: The chemokine receptor CXCR4 is essential for
vascularization of the gastrointestinal tract. Nature. 393:591–594.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vallabhapurapu S and Karin M: Regulation
and function of NF-kappaB transcription factors in the immune
system. Annu Rev Immunol. 27:693–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lenardo MJ and Baltimore D: NF-kappaB: A
pleiotropic mediator of inducible and tissue-specific gene control.
Cell. 58:227–229. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thompson JE, Phillips RJ,
Erdjument-Bromage H, Tempst P and Ghosh S: I kappa B-beta regulates
the persistent response in a biphasic activation of NF-kappa B.
Cell. 80:573–582. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
DiDonato JA, Hayakawa M, Rothwarf DM,
Zandi E and Karin M: A cytokine-responsive IkappaB kinase that
activates the transcription factor NF-kappaB. Nature. 388:548–554.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Greten FR, Arkan MC, Bollrath J, Hsu LC,
Goode J, Miething C, Göktuna SI, Neuenhahn M, Fierer J, Paxian S,
et al: NF-kappaB is a negative regulator of IL-1beta secretion as
revealed by genetic and pharmacological inhibition of IKKbeta.
Cell. 130:918–931. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rahighi S, Ikeda F, Kawasaki M, Akutsu M,
Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, et al:
Specific recognition of linear ubiquitin chains by NEMO is
important for NF-kappaB activation. Cell. 136:1098–1109. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ramdass B, Maliekal TT, Lakshmi S, Rehman
M, Rema P, Nair P, Mukherjee G, Reddy BK, Krishna S and
Radhakrishna Pillai M: Coexpression of Notch1 and NF-kappaB
signaling pathway components in human cervical cancer progression.
Gynecol Oncol. 104:352–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma XF, Zhang J, Shuai HL, Guan BZ, Luo X
and Yan RL: IKKβ/NF-κB mediated the low doses of bisphenol A
induced migration of cervical cancer cells. Arch Biochem Biophys.
573:52–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zheng X, Chen S, Yang Q, Cai J, Zhang W,
You H, Xing J and Dong Y: Salvianolic acid A reverses the
paclitaxel resistance and inhibits the migration and invasion
abilities of human breast cancer cells by inactivating transgelin
2. Cancer Biol Ther. 16:1407–1414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yakabe K, Murakami A, Kajimura T,
Nishimoto Y, Sueoka K, Sato S, Nawata S and Sugino N: Functional
significance of transgelin-2 in uterine cervical squamous cell
carcinoma. J Obstet Gynaecol Res. 42:566–572. 2016. View Article : Google Scholar : PubMed/NCBI
|
